Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital

Multicentre Double Blind Placebo Controlled Parallel Group Dose Ranging Study of ATL-962 to Assess Weight Loss, Safety and Tolerability in Obese Patients With Type II Diabetes Being Treated With Metformin, in Comparison With Orlistat

Project: Types of projects

View graph of relations
The purpose of this study is to investigate whether ATL-962 induces weight loss in diabetic patients and whether its safety and tolerability profile is superior to that of orlistat in such patients
Research programme<ingen navn>

ID: 32557220